Compounded semaglutide vs. Ozempic®: what's actually the difference?

The same molecule, delivered differently

Semaglutide is the active ingredient. Ozempic® and Wegovy® are brand-name products made by Novo Nordisk that contain semaglutide in a pre-filled injection pen. Compounded semaglutide is prepared by a state-licensed compounding pharmacy as a vial of medication that you draw up with a small insulin syringe.

In all three cases, the medication works the same way: semaglutide is a GLP-1 receptor agonist that reduces appetite, slows stomach emptying, and helps you feel satisfied with less food. The dosing ladder is also essentially the same — you start low (0.25 mg weekly) and increase gradually under a provider's supervision.

What's genuinely different

FDA status. This is the most important difference to understand. Ozempic and Wegovy are FDA-approved products — the agency has reviewed those specific products for safety, effectiveness, and manufacturing quality. Compounded semaglutide is not FDA-approved. Compounding is legal and regulated at the state level, and it exists so licensed pharmacies can prepare medications for individual patients — but the FDA has not reviewed any specific compounded product. That's why who compounds your medication matters so much.

The pharmacy. A reputable telehealth practice works with licensed U.S. compounding pharmacies that test for potency and sterility. Where you should be cautious: websites selling "semaglutide" without a prescription, without a licensed provider visit, or shipped from overseas. That's not compounding — that's a gray market, and it's where the horror stories come from.

The delivery method. Pens are convenient but locked to fixed doses. Vials require you to draw your dose with an insulin syringe — slightly more work, but it also means your provider can fine-tune your dose in smaller steps than the pen allows. If drawing a syringe sounds intimidating, our dose calculator converts your prescribed dose into exact syringe units.

The price. Brand-name GLP-1s commonly run $900–$1,300+ per month without insurance coverage. Compounded semaglutide at DonoMed starts at $150/month, including supplies and provider support. The difference isn't a different molecule — it's that you're not paying for the brand, the pen device, or the marketing.

Is compounded semaglutide safe?

The honest answer: it depends entirely on the prescriber and the pharmacy. The safety questions to ask any provider — including us — are:

• Is a licensed medical provider reviewing my health history before prescribing?
• Which pharmacy compounds the medication, and is it a licensed U.S. pharmacy?
• Do I know my exact dose in milligrams, and who do I contact with questions?
• Is there a real clinician available for follow-up and dose adjustments?

At DonoMed, every visit is reviewed by a Florida-licensed provider, medication ships from a licensed U.S. compounding pharmacy, and you can message your provider directly — not a call center.

Wait — Ozempic or Wegovy? A naming detour worth 30 seconds

Both are Novo Nordisk products containing semaglutide. Ozempic is FDA-approved for type 2 diabetes (and widely prescribed off-label for weight loss); Wegovy is the same molecule approved specifically for weight management at higher maximum doses. When people say "the Ozempic shot," they usually mean semaglutide generally. Compounded semaglutide sits beside both: same active ingredient, prepared per-patient by a compounding pharmacy instead of manufactured as a branded pen.

Can you switch between brand and compounded?

Clinically, yes — it's the same molecule, so providers routinely transition patients in either direction: brand-to-compounded when insurance coverage ends or the price becomes unsustainable, compounded-to-brand when coverage begins. The key is doing it with a provider who confirms your current dose and maps it correctly, because pens are labeled by dose and vials by concentration. That's exactly the kind of transition to never freelance on your own.

Red flags that should end the conversation

Whichever route you take, walk away from any source that: sells semaglutide without requiring a prescription and provider review; won't name its pharmacy; ships from outside the U.S.; sells "research chemicals" or peptides "not for human consumption" with a wink; or quotes a price that seems impossible even by compounding standards. The molecule being legitimate doesn't make every seller legitimate.

Which should you choose?

If your insurance covers a brand-name GLP-1 with an affordable copay, that's often worth taking — FDA-approved products are the default recommendation when they're accessible. Where compounded semaglutide makes sense is the situation most of our patients are in: insurance won't cover the brand, the cash price is out of reach, and a supervised, transparent program at a workable monthly cost is the difference between starting treatment and not starting at all.

Whatever you choose, the non-negotiable is medical supervision. GLP-1s are serious medications with real side effects and real contraindications — the medication should always come with a clinician attached.

Sources & further reading

• FDA — Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss
• FDA — Human Drug Compounding
• MedlinePlus — Semaglutide Injection